Search research articles
Contact Us
Filters
Showing results (101-110 of 146) with videos related to
Page
of 15
Sort By:
Cancer Management and Research
|
May 7, 2025
Real-World Efficacy and Safety of Anti-PD-1 Antibody Plus Apatinib and Temozolomide for Advanced Acral Melanoma
Jiaran Zhang, Huichun Tian, Lili Mao, et al.
Journal of Cancer
|
April 1, 2020
A Functional Synonymous Variant in <i>PDGFRA</i> Is Associated with Better Survival in Acral Melanoma
Jie Dai, Lu Yang, Tianxiao Xu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 22, 2022
Cumulative incidence and risk factors of brain metastasis for acral and mucosal melanoma patients with stages I-III
Yang Wang, Bin Lian, Lu Si, et al.
Ebiomedicine
|
April 27, 2020
Phase 1 trial of vorolanib (CM082) in combination with everolimus in patients with advanced clear-cell renal cell carcinoma
Xinan Sheng, Xieqiao Yan, Zhihong Chi, et al.
Clinical and Translational Medicine
|
January 6, 2025
Atezolizumab plus bevacizumab in patients with unresectable or metastatic mucosal melanoma: 3-year survival update and multi-omics analysis
Jie Dai, Tianxiao Xu, Lifeng Li, et al.
Innovation (Cambridge (Mass.))
|
June 17, 2024
IBI310 (anti-CTLA-4 antibody) monotherapy or in combination with sintilimab in advanced melanoma or urothelial carcinoma
Chuanliang Cui, Juan Li, Yue Yang, et al.
Cancer Research Communications
|
May 2, 2024
Comparative Epigenetic Profiling Reveals Distinct Features of Mucosal Melanomas Associated with Immune Cell Infiltration and Their Clinical Implications
Jie Dai, Jia Jia, Fanshuang Zhang, et al.
BMC Cancer
|
May 20, 2022
Safety, activity, and pharmacokinetics of camrelizumab in advanced Asian melanoma patients: a phase I study
Li Zhou, Xiaowen Wu, Zhihong Chi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 8, 2023
Apatinib combined with camrelizumab in advanced acral melanoma patients: An open-label, single-arm phase 2 trial
Xuan Wang, Xiaowen Wu, Yue Yang, et al.
Experimental Hematology & Oncology
|
June 2, 2026
Long-term survival benefit of neoadjuvant oncolytic virus plus PD-1 blockade in acral melanoma: implications of STING in resistance and potential therapy
Qian Zhao, Yu Du, Lifeng Li, et al.
Page
of 15
Search research articles
Search
Showing results (101-110 of 146) with videos related to
Sort By:
Page
of 15
Cancer Management and Research
|
May 7, 2025
Real-World Efficacy and Safety of Anti-PD-1 Antibody Plus Apatinib and Temozolomide for Advanced Acral Melanoma
Jiaran Zhang, Huichun Tian, Lili Mao, et al.
Journal of Cancer
|
April 1, 2020
A Functional Synonymous Variant in <i>PDGFRA</i> Is Associated with Better Survival in Acral Melanoma
Jie Dai, Lu Yang, Tianxiao Xu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 22, 2022
Cumulative incidence and risk factors of brain metastasis for acral and mucosal melanoma patients with stages I-III
Yang Wang, Bin Lian, Lu Si, et al.
Ebiomedicine
|
April 27, 2020
Phase 1 trial of vorolanib (CM082) in combination with everolimus in patients with advanced clear-cell renal cell carcinoma
Xinan Sheng, Xieqiao Yan, Zhihong Chi, et al.
Clinical and Translational Medicine
|
January 6, 2025
Atezolizumab plus bevacizumab in patients with unresectable or metastatic mucosal melanoma: 3-year survival update and multi-omics analysis
Jie Dai, Tianxiao Xu, Lifeng Li, et al.
Innovation (Cambridge (Mass.))
|
June 17, 2024
IBI310 (anti-CTLA-4 antibody) monotherapy or in combination with sintilimab in advanced melanoma or urothelial carcinoma
Chuanliang Cui, Juan Li, Yue Yang, et al.
Cancer Research Communications
|
May 2, 2024
Comparative Epigenetic Profiling Reveals Distinct Features of Mucosal Melanomas Associated with Immune Cell Infiltration and Their Clinical Implications
Jie Dai, Jia Jia, Fanshuang Zhang, et al.
BMC Cancer
|
May 20, 2022
Safety, activity, and pharmacokinetics of camrelizumab in advanced Asian melanoma patients: a phase I study
Li Zhou, Xiaowen Wu, Zhihong Chi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 8, 2023
Apatinib combined with camrelizumab in advanced acral melanoma patients: An open-label, single-arm phase 2 trial
Xuan Wang, Xiaowen Wu, Yue Yang, et al.
Experimental Hematology & Oncology
|
June 2, 2026
Long-term survival benefit of neoadjuvant oncolytic virus plus PD-1 blockade in acral melanoma: implications of STING in resistance and potential therapy
Qian Zhao, Yu Du, Lifeng Li, et al.
Page
of 15